The Hôpital du Sacré-Cœur de Montréal is a hospital in the Cartierville neighbourhood of Montreal, Quebec, Canada, bordering on Saint-Laurent. It is one of the largest teaching hospitals affiliated with the Université de Montréal, and one of the largest hospitals in Quebec.

There are 554 beds in Research Center, Hôpital Du Sacré-Coeur de Montréal.

During the past decade, Research Center, Hôpital Du Sacré-Coeur de Montréal conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Research Center, Hôpital Du Sacré-Coeur de Montréal" are "Fabry Disease" (2 trials). Many other conditions were trialed in "Research Center, Hôpital Du Sacré-Coeur de Montréal" in a lesser frequency.

Most popular intervention types in "Research Center, Hôpital Du Sacré-Coeur de Montréal" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lucerastat" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Research Center, Hôpital Du Sacré-Coeur de Montréal" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Research Center, Hôpital Du Sacré-Coeur de Montréal". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Research Center, Hôpital Du Sacré-Coeur de Montréal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Research Center, Hôpital Du Sacré-Coeur de Montréal, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".